Juan Wei

587 total citations
13 papers, 485 citations indexed

About

Juan Wei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Juan Wei has authored 13 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Juan Wei's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (4 papers). Juan Wei is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (4 papers). Juan Wei collaborates with scholars based in China, Canada and Brazil. Juan Wei's co-authors include Yongqian Shu, Chengjun Zhu, Yiqian Liu, Wen Gao, Ting Cheng, Yongqian Shu, Jinlong Tong, Yang Hua, Yongmei Yin and Wen Gao and has published in prestigious journals such as Advanced Science, Clinical Microbiology and Infection and Journal of Cellular Biochemistry.

In The Last Decade

Juan Wei

12 papers receiving 480 citations

Peers

Juan Wei

MB

CR

PRM

ONCOL

EPIDE

Haipo Xu China

Emre Basar United States

Samireh Jorfi United Kingdom

Anne Schlegel Germany

Nadim Tawil Canada

Wen Su China

Ali Shojaeian Iran

Noraini Abd-Aziz Malaysia

Joeri Tulkens Belgium

Javier Freire Spain

Haipo Xu China

Juan Wei

243 ×0.7

MB

196 ×0.7

CR

70 ×1.4

PRM

60 ×1.2

ONCOL

47 ×1.2

EPIDE

Citations per year, relative to Juan Wei Juan Wei (= 1×) peers Haipo Xu

Countries citing papers authored by Juan Wei

Since Specialization

Citations

This map shows the geographic impact of Juan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Wei more than expected).

Fields of papers citing papers by Juan Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Wei. The network helps show where Juan Wei may publish in the future.

Co-authorship network of co-authors of Juan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Wei. A scholar is included among the top collaborators of Juan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Wei. Juan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Zhai, Jie, Yuxin Zhou, Juan Wei, et al.. (2025). PT_f‐SRiApt Targeting SCAF4‐POLR2A Interaction Suppresses Tumor Growth and Promotes Antitumor Immunity in Triple‐Negative Breast Cancer. Advanced Science. 12(35). e00433–e00433. 1 indexed citations

2.

Wei, Juan, Xueyuan Zhou, Yong Wei, et al.. (2025). Protocol to identify small-molecule inhibitors against cancer drug resistance. STAR Protocols. 6(1). 103605–103605.

3.

Zhang, Kejing, Juan Wei, Xueying Liu, et al.. (2024). A chemical screen identifies PRMT5 as a therapeutic vulnerability for paclitaxel-resistant triple-negative breast cancer. Cell chemical biology. 31(11). 1942–1957.e6. 9 indexed citations

4.

Wu, Huimin, Juan Wei, Jin Li, et al.. (2019). Serum Procalcitonin as a Potential Early Predictor of Short-Term Outcomes in Acute Severe Ulcerative Colitis. Digestive Diseases and Sciences. 64(11). 3263–3273. 17 indexed citations

5.

Wei, Juan, Hanfeng Xu, Zhaojing Wang, et al.. (2019). Circular RNA hsa_circRNA_102958 may serve as a diagnostic marker for gastric cancer. Cancer Biomarkers. 27(2). 139–145. 65 indexed citations

6.

Liu, Yanqing, Xiaorui Chen, Yi Zhao, et al.. (2019). miR‐144 suppresses cell proliferation and migration in colorectal cancer by targeting NRAS. Journal of Cellular Biochemistry. 121(8-9). 3871–3881. 7 indexed citations

7.

Li, Jun, Juan Wei, Zhu Mei, et al.. (2017). Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44.. PubMed. 9(1). 146–154. 33 indexed citations

8.

Hua, Yang, et al.. (2013). The role and mechanisms of nanoparticles to enhance radiosensitivity in hepatocellular cell. Biomedicine & Pharmacotherapy. 67(7). 569–575. 53 indexed citations

9.

Zhang, Jinying, Lingjun Zhu, Juan Wei, et al.. (2012). The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study. Journal of Cancer Research and Clinical Oncology. 138(6). 1057–1062. 27 indexed citations

10.

Wei, Juan, Wen Gao, Chengjun Zhu, et al.. (2011). Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chinese Journal of Cancer. 30(6). 407–414. 180 indexed citations

11.

Guo, Hongxiong, et al.. (2011). Detection and identification of plasma bacterial and viral elements in HIV/AIDS patients in comparison to healthy adults. Clinical Microbiology and Infection. 18(11). 1126–1133. 57 indexed citations

12.

Wei, Juan, Lianke Liu, Wen Gao, et al.. (2011). Reduction of plasma MicroRNA-21 is associated with chemotherapeutic response in patients with non-small cell lung cancer. Chinese Journal of Cancer Research. 23(2). 123–128. 26 indexed citations

13.

Wei, Juan, et al.. (2011). Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chinese Journal of Cancer. 407–414. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact